ad

Global Health Share Price Falls 2.79% After Q1 Results

Global Health falls 2.79% to Rs 1,376.90. Q1 FY27 PAT Rs 158.7 crore vs Rs 159 crore (-0.2% YoY). Revenue Rs 1,304 crore vs Rs 1,031 crore approx (+26.5% YoY).


31 Jul 202612:24 pm

Global Health Share Price Falls 2.79% After Q1 Results

The Global Health share price fall after Q1 results theme was in focus on Friday, with Global Health shares moving 2.79% to Rs 1,376.90, from a previous close of Rs 1,416.40, after the company reported its results for the quarter ended June 2026.

Global Health reported a profit after tax of Rs 158.7 crore for Q1 FY27, against Rs 159 crore in the year-ago quarter, a change of -0.2%. Revenue for the quarter stood at Rs 1,304 crore, compared with Rs 1,031 crore approx a year earlier, a change of +26.5%.

Click Here – Get Free Investment Predictions

Global Health Q1 FY27 Results: Key Numbers

Metric Q1 FY27 Q1 FY26 YoY Change
Profit After Tax Rs 158.7 crore Rs 159 crore -0.2%
Revenue Rs 1,304 crore Rs 1,031 crore approx +26.5%

Why Global Health Shares Moved 2.79% Today

Check the Univest Screener for sector-linked stocks

Revenue grew strongly on higher patient volumes, though profit stayed nearly flat as the network continues to expand and absorb new-hospital costs.

About Global Health

Operator of Medanta hospitals, a multi-specialty healthcare chain with tertiary and quaternary care centres.

Download the Univest iOS App or Univest Android App to track Global Health's stock price and quarterly results.

What to Watch Going Forward

Investors tracking Global Health should watch management commentary on demand trends, cost pressures and full-year guidance in the coming quarters, since forward-looking statements often matter as much as the headline quarterly numbers for how the stock trades over the following weeks.

Conclusion

The Global Health share price fall after Q1 results move reflects the market's reaction to the company's latest quarterly performance. Investors should evaluate the stock against its own growth trajectory and valuation, and consult a SEBI-registered financial advisor before making any investment decision.

Investors continuing to track the Global Health share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Global Health share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Global Health share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Global Health share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Global Health share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Global Health share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Global Health share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Global Health share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Global Health share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Global Health share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Global Health share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Global Health share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Global Health share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Global Health share price fall after Q1 results story should watch how the stock trades in the sessions ahead.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on Global health share price fall after q1 results

Why did Global Health share price fall after Q1 results?

Ans. Global Health shares moved 2.79% after the company reported Q1 FY27 profit after tax of Rs 158.7 crore, a change of -0.2% from Rs 159 crore a year earlier, on revenue of Rs 1,304 crore.

What was Global Health's profit in Q1 FY27?

Ans. Global Health reported a profit after tax of Rs 158.7 crore for the quarter ended June 2026, compared with Rs 159 crore in the same quarter a year earlier.

What was Global Health's revenue in Q1 FY27?

Ans. Global Health's revenue for Q1 FY27 stood at Rs 1,304 crore, compared with Rs 1,031 crore approx a year earlier, a change of +26.5%.

What is Global Health's current share price?

Ans. Global Health shares were trading at Rs 1,376.90 today, falling 2.79% from the previous close of Rs 1,416.40.

Should I buy Global Health shares after the Q1 results move?

Ans. Investment decisions should be based on individual research and risk appetite; consult a SEBI-registered financial advisor before buying or selling shares after any results-driven move.

Where can I track Global Health's live share price?

Ans. Global Health's live share price and quarterly result updates can be tracked on the Univest platform alongside SEBI-registered research.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down